Avoid common mistakes on your manuscript.
Correction to: Diabetes Ther https://doi.org/10.1007/s13300-019-00728-6
In the original article, Associated Medical Education Section has been published mistakenly. It has been removed from the original publication.
The original version of this article was revised.
Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Evans, M., Hicks, D., Patel, D. et al. Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes. Diabetes Ther 11, 571 (2020). https://doi.org/10.1007/s13300-019-00752-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13300-019-00752-6